Suppr超能文献

年轻、有能力且强壮(YES):一项针对青少年和青年成人(AYA)乳腺癌幸存者的移动健康症状监测与自我管理干预随机对照试验的研究方案论文

Young, Empowered & strong (YES): a study protocol paper for a randomized controlled trial of an mHealth symptom monitoring and self-management intervention for adolescent and young adult (AYA) breast cancer survivors.

作者信息

Dibble Kate E, Rosenberg Shoshana M, Snow Craig, Kirkner Gregory J, Tayob Nabihah, Contreras Magnolia, Roma Noel D, DeGraffinreid Cecilia R, Nolan Timiya S, Hershman Dawn L, Naughton Michelle, Partridge Ann H

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Department of Medicine, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.

出版信息

BMC Public Health. 2025 Jan 11;25(1):126. doi: 10.1186/s12889-025-21288-4.

Abstract

BACKGROUND

Compared to older adults with breast cancer (BC), adolescents and young adults (AYAs) develop more aggressive disease necessitating more intensive therapy with curative intent, which is disruptive to planned life trajectories. The burden of unmet needs among AYA BC survivors exists in two domains: (1) symptoms (e.g., sexual problems, anxiety, fatigue, stress, hot flashes) and (2) AYA concerns (e.g., fertility, genetics, relationships, economic attainment). Improved attention to concerns and symptoms may improve symptom management and quality of life. The Young, Empowered and Strong (YES) trial tests the efficacy of a 9-month, multicomponent digital health intervention that includes monthly assessments of prevalent symptoms, a chat room, and journal to engage and support AYAs with BC by providing tailored information, resources, and support outside of the clinical setting.

METHODS

YES is a multicenter, randomized controlled trial across three academic institutions in the United States with 400 participants randomized to either the YES intervention or usual care arm. Inclusion criteria include biologically female; 15-39 years of age at diagnosis of stage 0-III BC; within 3 years of diagnosis; no known evidence of recurrence; no prior history of new malignancy since initial BC diagnosis; and ability to access medical records from treatment site. All participants complete REDCap surveys at baseline, and at 3, 6, and 9 months post-enrollment. The primary outcome is quality of life as measured by the Quality of Life in Adult Cancer Survivors Scale (QLACS), with changes from baseline to 6-months in QLACS scores, compared by arm. Secondary outcomes include patient reported AYA concerns/needs, emotional symptoms, general health, physical symptoms, and health behaviors, DISCUSSION: Study findings will provide valuable insight into the ability of the YES digital health intervention to address symptoms and concerns of AYA BC survivors and assist them to track and self-manage their own symptoms, concerns, and needs related to their cancer outside of the clinic.

TRIAL REGISTRATION

Clinicaltrials.gov, NCT04906200, registered May 13, 2021.

摘要

背景

与老年乳腺癌患者相比,青少年及年轻成人(AYA)患的乳腺癌更具侵袭性,需要更强化的治疗以达到治愈目的,而这会扰乱他们原本规划的人生轨迹。AYA乳腺癌幸存者未满足需求的负担存在于两个方面:(1)症状(如性问题、焦虑、疲劳、压力、潮热)和(2)AYA所关注的问题(如生育、遗传、人际关系、经济成就)。对这些关注问题和症状给予更多关注可能会改善症状管理和生活质量。“年轻、赋权与强大(YES)”试验旨在测试一项为期9个月的多成分数字健康干预措施的效果,该干预措施包括每月对常见症状进行评估、设立一个聊天室以及提供日志,通过在临床环境之外提供量身定制的信息、资源和支持,来吸引和支持患有乳腺癌的AYA。

方法

YES是一项在美国三所学术机构开展的多中心随机对照试验,400名参与者被随机分配至YES干预组或常规护理组。纳入标准包括生物学女性;确诊为0 - III期乳腺癌时年龄在15 - 39岁之间;确诊后3年内;无已知复发证据;自最初确诊乳腺癌后无新发恶性肿瘤病史;以及能够获取治疗机构的病历记录。所有参与者在基线时以及入组后3个月、6个月和9个月完成REDCap调查问卷。主要结局指标是采用成人癌症幸存者生活质量量表(QLACS)测量的生活质量,比较两组从基线到6个月时QLACS评分的变化。次要结局指标包括患者报告的AYA关注的问题/需求、情绪症状、总体健康状况、身体症状和健康行为。

讨论

研究结果将为YES数字健康干预措施解决AYA乳腺癌幸存者的症状和关注问题以及帮助他们在临床环境之外跟踪和自我管理与癌症相关的自身症状、关注问题和需求的能力提供有价值的见解。

试验注册

Clinicaltrials.gov,NCT04906200,于2021年5月13日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb71/11724548/6048654ce54e/12889_2025_21288_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验